Permanent Injury Caused by GranuFlo

GranuFlo was introduced as a dialysis drug for kidney failure in the 1940’s, quickly becoming a much needed and widely used medical option for individuals suffering from kidney damage. Recently, however, the U.S. Food and Drug Administration issued a Class 1 recall on the drug. According to the website of Williams Kherkher, an anonymous person sent in an internal document from Fresenius, the drug manufacturer, that linked GranuFlo with up to 941 cases of cardiac arrest.

Out of the 400,000 Americans receiving dialysis treatment, Fresenius Medical Care serves more than one third of them. The released report showed that patients with higher levels of bicarbonate, the substance GranuFlo administers to the dialysis patient, were six times more likely to suffer cardiac attacks than those with lower levels. It is reported that up to 30 percent of patients exhibited a bicarbonate level that was too high.

The increased bicarbonate in the bloodstream caused by GranuFlo causes the pH levels to become too acidic, leading to metabolic alkalosis. Metabolic alkalosis is a serious side effect of GranuFlo that can lead to significant health problems such as heart arrhythmias, comas, heart attacks, or death.

The accusation that Fresenius was aware of the potential health risks associated with its product would mean the company is responsible for the wrongful deaths of its clients. The website of Franklin, Wisconsin personal injury lawyers defines wrongful death as the loss a person dude to the irresponsible or reckless actions of another party.

If you or a loved one has suffered due to Fresenius and its product GranuFlo, consult a personal injury attorney in your state to discuss legal options and compensation.

Leave a Reply

Your email address will not be published. Required fields are marked *